首页/数据集/Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme

Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme

NCATS Open Data2021-11-19 更新2026-08-08 收录

流感疫苗免疫原性

疫苗安全性评估

数据链接：

https://doi.org/10.1101/2021.11.14.21266309 数据链接链接失效反馈

官方服务：

资源简介：

Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme

应用场景：

创建时间：

2021-11-15

疫苗安全性评估

流感病毒减毒机制

Peste des Petits Ruminants (PPR) is a highly infectious disease caused by a virus of the Morbillivirus genus. The current PPR eradication effort relies mainly on the implementation of massive vaccinat

NIAID Data Ecosystem80

Evaluation of the histopathological damages in the lungs of rhesus macaques vaccinated with low dose SWIM516.

疫苗安全性评估

肺部病理学

Scores 0, 1, 2 and 3 indicate no, mild, medium and severe histopathological damage, respectively. (UL: upper left; ML: middle left; LL: lower left; UR: upper right; MR: middle right; LR: lower right).

Figshare2024-04-01 更新50

Assessing recombination between self-amplifying mRNA vaccines and wild-type alphaviruses in vitro and in vivo

疫苗安全性评估

病毒重组检测

GETV and SAM vaccine were co-injected subcutaneously into the hind feet of 6-10 week old female IFNAR-/-, Rag-/-, and C57BL/6J mice. Feet were harvested at various time points, and had RNA sequenced b

NIAID Data Ecosystem30

Hemagglutination-Inhibition Titer

流感疫苗免疫原性

血凝抑制试验抗体滴度

aDose based upon HA contentbInfluenza viruses used in the HAI assay against sera collected at week 5.cHAI GMT plus or minus SEM.dVLP vs. rHA comparing same dose, t-test, *p

Figshare2015-12-02 更新70

Q values for reported symptoms in pre-vaccinated participants.

疫苗临床试验症状分析

疫苗安全性评估

Q values for reported symptoms in pre-vaccinated participants.

NIAID Data Ecosystem40